This document provides recommendations developed by the ESPGHAN Working Group on Probiotics and Prebiotics on the role of probiotics in the prevention of nosocomial diarrhea in children based on a systematic review of previously completed systematic reviews and of subsequently published randomized controlled trials. The quality of evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation guidelines. Recommendations were given only if at least 2 randomized controlled trials examined the same probiotic strain. Based on currently available evidence the Working Group recommends using Lactobacillus rhamnosus GG if the use of probiotics for preventing nosocomial diarrhea in children is considered
Aim: The use of probiotics has been covered by many guidelines, position papers and evidence-based r...
Since the publication of the 2014 European Society for Paediatric Gastroenterology, Hepatology, and ...
Diarrhea remains the second leading cause of death in children below 5 years of age; in addition it ...
This document provides recommendations developed by the ESPGHAN Working Group (WG) on Probiotics and...
This article provides recommendations, developed by the Working Group (WG) on Probiotics of the Euro...
This manuscript proposes recommendations for the use of probiotics for the counteraction of an anti-...
This paper proposes recommendations for the use of probiotics for the counteraction of an anti-infec...
_The use of probiotics has been covered by many guidelines, position papers and evidence-based recom...
Background: This review was designed to assess the evidence from randomized controlled trials on eff...
Probiotics are increasingly used for prevention and treatment of diarrhea more in children than in a...
Since the publication of the 2014 ESPGHAN Working Group (WG) on Probiotics & Prebiotics guidelines o...
Prophylactic and therapeutic administration of prebiotics in treatment of different disorders is use...
Antibiotic associated diarrhea (AAD) is a common complication in childhood in the outpatient and inp...
The use of probiotics has been suggested in the treatment of acute gastroenteritis (AGE) in addition...
Aim: The use of probiotics has been covered by many guidelines, position papers and evidence-based r...
Since the publication of the 2014 European Society for Paediatric Gastroenterology, Hepatology, and ...
Diarrhea remains the second leading cause of death in children below 5 years of age; in addition it ...
This document provides recommendations developed by the ESPGHAN Working Group (WG) on Probiotics and...
This article provides recommendations, developed by the Working Group (WG) on Probiotics of the Euro...
This manuscript proposes recommendations for the use of probiotics for the counteraction of an anti-...
This paper proposes recommendations for the use of probiotics for the counteraction of an anti-infec...
_The use of probiotics has been covered by many guidelines, position papers and evidence-based recom...
Background: This review was designed to assess the evidence from randomized controlled trials on eff...
Probiotics are increasingly used for prevention and treatment of diarrhea more in children than in a...
Since the publication of the 2014 ESPGHAN Working Group (WG) on Probiotics & Prebiotics guidelines o...
Prophylactic and therapeutic administration of prebiotics in treatment of different disorders is use...
Antibiotic associated diarrhea (AAD) is a common complication in childhood in the outpatient and inp...
The use of probiotics has been suggested in the treatment of acute gastroenteritis (AGE) in addition...
Aim: The use of probiotics has been covered by many guidelines, position papers and evidence-based r...
Since the publication of the 2014 European Society for Paediatric Gastroenterology, Hepatology, and ...
Diarrhea remains the second leading cause of death in children below 5 years of age; in addition it ...